Maciej Bryl

Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study

M. Roszak, Alessio Campisi, C. Piwkowski, 2024, Cancers.

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

A. Rittmeyer, Martin Reck, Charles M. Rudin, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

P. Krawczyk, D. Kowalski, E. Kalinka, 2024, Frontiers in oncology.